We’re excited to take part in AI4Immuno-Oncology, co-organized by Future4care and the Paris Saclay Cancer Cluster—a key event exploring how artificial intelligence is transforming the field of immuno-oncology.
AI is no longer just optimizing healthcare; it’s reshaping it. From discovery to treatment, data-driven technologies are opening new frontiers in precision medicine.
At Mabqi, we believe in the power of AI to accelerate innovation and deliver more effective, targeted therapies. We’re proud to be part of this collaborative effort to unlock the next era of cancer care.
